Status:
COMPLETED
Greatest International Antiinfective Trial With Avelox
Lead Sponsor:
Bayer
Conditions:
Bronchitis, Chronic
Bronchial Diseases
Eligibility:
All Genders
12+ years
Brief Summary
The observation period for each patient covered an initial treatment period with Avelox® plus optional 2 long-term follow-up periods (6 and 12 months).For each patient, the physician documented data a...
Eligibility Criteria
Inclusion
- Outpatients with diagnosis of AECB and decision taken by the investigator to prescribe moxifloxacin
Exclusion
- Exclusion criteria must be read in conjunction with the local product information
Key Trial Info
Start Date :
February 1 2004
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
November 1 2007
Estimated Enrollment :
50000 Patients enrolled
Trial Details
Trial ID
NCT00932802
Start Date
February 1 2004
End Date
November 1 2007
Last Update
November 19 2012
Active Locations (24)
Enter a location and click search to find clinical trials sorted by distance.
1
Many Locations, Austria
2
Many Locations, Brazil
3
Many Locations, China
4
Many Locations, Colombia